|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 25, No 5 (February 10), 2007: pp. 604 © 2007 American Society of Clinical Oncology. DOI: 10.1200/JCO.2006.09.4722
In ReplyGeneva Cancer Registry, Institute for Social and Preventive Medicine, University of Geneva, Geneva, Switzerland We appreciate the interest of Drs Choi and Robins in our study. 1 They argue that the survival benefit of surgery of the primary tumor does not derive from prevention of new metastases because the survival curves diverged from the beginning. Such a conclusion, however, can not be drawn from curves predicted from a multiadjusted Cox model. The Cox model assumes that the ratio of hazard functions is constant over time and at any time of the study the two hazard functions are proportional to one other. Therefore, they are simply not suitable for conclusions on timing of diverging. We agree with the authors, however, that the reason for better survival of patients who could undergo complete resection of the primary tumor is far from being understood. We also agree, and in the article we acknowledged it, that even after all our efforts to reduce the selection bias due to unrecorded factors, a residual confounding is still likely. For these reasons we conclude that only a clinical trial will be able to test our hypothesis. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The authors indicated no potential conflicts of interest. ACKNOWLEDGMENTS Supported in part by PROSPER Grant No. 323-3069350 from the Swiss National Science Foundation (H.M.V.). REFERENCES
1. Rapiti E, Verkooijen HM, Vlastos G, et al: Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24:2743-2749, 2006
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|